Gross & Hartman Investments’s Sabra Healthcare REIT SBRA Stock Holding History

Gross & Hartman Investments’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	+11,098	New	+$220K	0.1%	77

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

LIMS

Lasalle Investment Management Securities Baltimore, Maryland $2.81B AUM 16.57% 1-Year Est. Return

Gross & Hartman Investments's SBRA Position: Q2 2026 in Review

Gross & Hartman Investments opened a new position in Sabra Healthcare REIT (SBRA) in Q2 2026: 11,098 shares worth $217K. The stake represents 0.1% of the portfolio and ranks #77 among its holdings.

429 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Gross & Hartman Investments held 11,098 shares of Sabra Healthcare REIT worth $217K as of Q2 2026.
Sabra Healthcare REIT was a new Gross & Hartman Investments position in Q2 2026.
Sabra Healthcare REIT made up 0.1% of Gross & Hartman Investments's portfolio in Q2 2026, its #77 holding.
429 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Gross & Hartman Investments's 13F filing for Q2 2026, filed 13 Aug 2026.